Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 46.9 TWD -0.21% Market Closed
Market Cap: 4.2B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Intrinsic Value

The intrinsic value of one Maxigen Biotech Inc stock under the Base Case scenario is 30.42 TWD. Compared to the current market price of 46.9 TWD, Maxigen Biotech Inc is Overvalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
30.42 TWD
Overvaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Maxigen Biotech Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Maxigen Biotech Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Maxigen Biotech Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Maxigen Biotech Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

46.9 TWD
-0.21%
-0.21%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Maxigen Biotech Inc
TW
Consumer products
Market Cap
4.2B TWD
IPO
May 18, 2011
Employees
-
Taiwan
Market Cap
4.2B TWD
Industry
Consumer products
IPO
May 18, 2011
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Maxigen Biotech Inc

Provide an overview of the primary business activities
of Maxigen Biotech Inc.

What unique competitive advantages
does Maxigen Biotech Inc hold over its rivals?

What risks and challenges
does Maxigen Biotech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Maxigen Biotech Inc.

Provide P/S
for Maxigen Biotech Inc.

Provide P/E
for Maxigen Biotech Inc.

Provide P/OCF
for Maxigen Biotech Inc.

Provide P/FCFE
for Maxigen Biotech Inc.

Provide P/B
for Maxigen Biotech Inc.

Provide EV/S
for Maxigen Biotech Inc.

Provide EV/GP
for Maxigen Biotech Inc.

Provide EV/EBITDA
for Maxigen Biotech Inc.

Provide EV/EBIT
for Maxigen Biotech Inc.

Provide EV/OCF
for Maxigen Biotech Inc.

Provide EV/FCFF
for Maxigen Biotech Inc.

Provide EV/IC
for Maxigen Biotech Inc.

Show me price targets
for Maxigen Biotech Inc made by professional analysts.

What are the Revenue projections
for Maxigen Biotech Inc?

How accurate were the past Revenue estimates
for Maxigen Biotech Inc?

What are the Net Income projections
for Maxigen Biotech Inc?

How accurate were the past Net Income estimates
for Maxigen Biotech Inc?

What are the EPS projections
for Maxigen Biotech Inc?

How accurate were the past EPS estimates
for Maxigen Biotech Inc?

What are the EBIT projections
for Maxigen Biotech Inc?

How accurate were the past EBIT estimates
for Maxigen Biotech Inc?

Compare the revenue forecasts
for Maxigen Biotech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Maxigen Biotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Maxigen Biotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Maxigen Biotech Inc compared to its peers.

Compare the P/E ratios
of Maxigen Biotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Maxigen Biotech Inc with its peers.

Analyze the financial leverage
of Maxigen Biotech Inc compared to its main competitors.

Show all profitability ratios
for Maxigen Biotech Inc.

Provide ROE
for Maxigen Biotech Inc.

Provide ROA
for Maxigen Biotech Inc.

Provide ROIC
for Maxigen Biotech Inc.

Provide ROCE
for Maxigen Biotech Inc.

Provide Gross Margin
for Maxigen Biotech Inc.

Provide Operating Margin
for Maxigen Biotech Inc.

Provide Net Margin
for Maxigen Biotech Inc.

Provide FCF Margin
for Maxigen Biotech Inc.

Show all solvency ratios
for Maxigen Biotech Inc.

Provide D/E Ratio
for Maxigen Biotech Inc.

Provide D/A Ratio
for Maxigen Biotech Inc.

Provide Interest Coverage Ratio
for Maxigen Biotech Inc.

Provide Altman Z-Score Ratio
for Maxigen Biotech Inc.

Provide Quick Ratio
for Maxigen Biotech Inc.

Provide Current Ratio
for Maxigen Biotech Inc.

Provide Cash Ratio
for Maxigen Biotech Inc.

What is the historical Revenue growth
over the last 5 years for Maxigen Biotech Inc?

What is the historical Net Income growth
over the last 5 years for Maxigen Biotech Inc?

What is the current Free Cash Flow
of Maxigen Biotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Maxigen Biotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Maxigen Biotech Inc

Current Assets 744.2m
Cash & Short-Term Investments 545.3m
Receivables 112.7m
Other Current Assets 86.3m
Non-Current Assets 788.7m
Long-Term Investments 346.7m
PP&E 433m
Intangibles 161k
Other Non-Current Assets 8.8m
Current Liabilities 196.6m
Accounts Payable 47.1m
Accrued Liabilities 68.5m
Other Current Liabilities 81.1m
Non-Current Liabilities 1.7m
Other Non-Current Liabilities 1.7m
Efficiency

Earnings Waterfall
Maxigen Biotech Inc

Revenue
623.8m TWD
Cost of Revenue
-188.9m TWD
Gross Profit
434.9m TWD
Operating Expenses
-285.8m TWD
Operating Income
149.1m TWD
Other Expenses
6.3m TWD
Net Income
155.3m TWD

Free Cash Flow Analysis
Maxigen Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Maxigen Biotech Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score

Maxigen Biotech Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Maxigen Biotech Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Maxigen Biotech Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Maxigen Biotech Inc

There are no price targets for Maxigen Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Maxigen Biotech Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Maxigen Biotech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Maxigen Biotech Inc stock?

The intrinsic value of one Maxigen Biotech Inc stock under the Base Case scenario is 30.42 TWD.

Is Maxigen Biotech Inc stock undervalued or overvalued?

Compared to the current market price of 46.9 TWD, Maxigen Biotech Inc is Overvalued by 35%.

Back to Top